首页 | 官方网站   微博 | 高级检索  
     

新辅助化疗所致预后营养指数降低预示乳腺癌患者预后不良:一项单中心回顾性队列研究
引用本文:梁丽红,王维,杨芳.新辅助化疗所致预后营养指数降低预示乳腺癌患者预后不良:一项单中心回顾性队列研究[J].中国癌症防治杂志,2022,14(2):184-189.
作者姓名:梁丽红  王维  杨芳
作者单位:首都医科大学附属北京世纪坛医院肿瘤内科
基金项目:北京市医院管理局重点医学专业发展计划(ZYLX201816)
摘    要:目的 评估预后营养指数(prognostic nutritional index,PNI)变化对接受新辅助化疗(neoadjuvant chemotherapy,NAC)乳腺癌患者预后的影响。方法 本研究为一项单中心、回顾性队列研究。选2008年1月至 2017 年12月在本院接受NAC和手术切除的乳腺癌患者为研究对象,随访截至2020年12月。主要研究终点为无病生存期。采用时间依赖的ROC曲线计算NAC前PNI(pre-PNI)、NAC后PNI(post-PNI)以及NAC前后 PNI(ΔPNI)的截断值,采用Cox比例风险回归分析PNI与无病生存期的关联性。结果 共131例患者符合标准纳入研究。NAC后PNI较NAC前降低(46.4±4.5 vs 52.5±4.2,P<0.001)。ΔPNI的截断值为5.26。高ΔPNI 组的无病生存率明显低于低 ΔPNI 组(P<0.001)。多因素Cox比例风险回归显示,ΔPNI、NAC前的临床分期、HER-2均是无病生存期的独立影响因素(均P<0.05)。结论  NAC期间PNI降低提示预后不良。在NAC期间保持良好营养状态可能会为乳腺癌患者带来更好的治疗结果。


Decreased prognostic nutritional index caused by neoadjuvant chemotherapy indicates poor prognosis for breast cancer patients: a singlecenter retrospective cohort study
LIANG Lihong,WANG Wei,YANG Fang.Decreased prognostic nutritional index caused by neoadjuvant chemotherapy indicates poor prognosis for breast cancer patients: a singlecenter retrospective cohort study[J].Chinese Journal of Oncology Prevention and Treatment,2022,14(2):184-189.
Authors:LIANG Lihong  WANG Wei  YANG Fang
Abstract:Objective To evaluate the impact of the prognostic nutritional index (PNI) on the prognosis of the breast cancer patients receiving neoadjuvant chemotherapy (NAC). Methods A single-center, retrospective cohort study was performed on the breast cancer patients, who underwent NAC and surgical resection in Internal Medicine-Oncology Beijing Shijitan Hospital Affiliated to Capital Medical University from January 2008 to December 2017, were selected as the research subjects, and the follow-up was as of December 2020. The main study endpoint was the disease-free survival. The cut-off values of PNI before NAC (pre-PNI), PNI after NAC (post-PNI), and PNI before and after NAC (ΔPNI) were calculated by the time-dependent ROC curve. The association between PNI and disease-free survival was analyzed by Cox proportional hazard regression. Results A total of 131 patients met the criteria. The post-PNI was lower than pre-PNI (46.4±4.5 vs 52.5±4.2, P<0.001). The cut-off value of ΔPNI was 5.26. The disease-free survival rate of the high ΔPNI group was significantly lower than that of the low ΔPNI group (P<0.001). Further multivariable Cox proportional hazard regression showed that ΔPNI, pre-NAC clinical stage, and HER-2 were independent influencing factors of the disease-free survival (all P<0.05). Conclusions The decrease in PNI during NAC indicates a poor prognosis. Maintaining a nutritional status during NAC may yield better treatment results for the breast cancer patients.
Keywords:Breast cancer  Prognostic nutritional index  Neoadjuvant chemotherapy  Disease-free survival  
点击此处可从《中国癌症防治杂志》浏览原始摘要信息
点击此处可从《中国癌症防治杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号